Incentivising Appropriate Malaria Treatment-seeking Behaviour with Price Subsides

摘要: One of the most serious problems in fight against malaria, especially Africa, is fact that many individuals suffering from malaria do not have easy access to effective antimalarials while at same time a large proportion people receiving suffer malaria. In order improve access, global price subsidy 95% has been proposed for antimalarial, artemisininbased combination therapy (ACT). The objective this proposal lower consumer on medicine increase for, particular, poor consumers. However, treatment patients with including ACTs proven widespread and likely overtreatment. This means waste resources will result inflating funds required. addition, as happened older types medicine, treating nonmalarial fevers may risk artemisinin resistance development. Diagnostic tests potential reducing overtreatment, but are expensive typical treatmentseeking individual. both reduce overtreatment we propose rapid diagnostic (RDTs) together ACT subsidy. main paper investigate optimal subsidies incentivises suspecting themselves always test before buying an drug. We present model describes health seeking behaviour representative individual using expected utility framework. Based numerical simulations our find reduction RDTs necessary incentivise testing time, can be than without compromising access. leastcost policy maker subsidise RDT, redirecting some money RDT.